Unibest 优贝德
← Back to patent-cliff list

可美替尼

Tier C — Watch / trade

Cobimetinib Fumarate · all drugs expiring in 2029 →

Exelixis Inc
Originator
2015
First approval
2029
Expiry (public)
$0.2B *
Peak sales
化学药
Type

TargetsMEK2、MEK1

BrandCotellic

Indications (approved)黑色素瘤

Regional status

US
批准上市
2015-11-10
EU
批准上市
2015-02-27
China
临床一期
2017-06-09
Japan
-

Synthetic routes & intermediates3 routes

Originator routes × 1Optimised (non-patent) × 1Process routes × 1

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 10 · Total yield /
Synthetic routes & intermediates Route 1
CodeCAS No.Intermediate
COBI-00118621-18-6azetidin-3-ol hydrochloride
COBI-002128117-22-6benzyl 3-hydroxyazetidine-1-carboxylate
COBI-003105258-93-3benzyl 3-oxoazetidine-1-carboxylate
COBI-00475844-69-8tert-butyl piperidine-1-carboxylate
COBI-005934664-27-4tert-butyl 2-(1-((benzyloxy)carbonyl)-3-hydroxyazetidin-3-yl)piperidine-1-carboxylate
COBI-00639637-99-5(R)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoyl chloride
COBI-007934665-53-9(S)-tert-butyl 2-(1-((benzyloxy)carbonyl)-3-(((R)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoyl)oxy)azetidin-3-yl)piperidine-1-carboxylate
COBI-008934665-55-1(S)-tert-butyl 2-(1-((benzyloxy)carbonyl)-3-hydroxyazetidin-3-yl)piperidine-1-carboxylate
COBI-009934666-39-4(S)-tert-butyl 2-(3-hydroxyazetidin-3-yl)piperidine-1-carboxylate
COBI-010934664-19-43,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzoyl fluoride
COBI-011934663-52-2(S)-tert-butyl 2-(1-(3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzoyl)-3-hydroxyazetidin-3-yl)piperidine-1-carboxylate
COBI-01261079-72-92,3,4-trifluorobenzoic acid
COBI-01329632-74-4Available2-fluoro-4-iodoaniline
COBI-014391211-97-53,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzoic acid
COBI-015675-14-92,4,6-trifluoro-1,3,5-triazine
OptimisedRoute 2Steps 6 · Total yield 20.66 g
Synthetic routes & intermediates Route 2
CodeCAS No.Intermediate
COBI-01261079-72-92,3,4-trifluorobenzoic acid
COBI-01329632-74-4Available2-fluoro-4-iodoaniline
COBI-016106565-71-3(3S,5R,8aS)-3-phenylhexahydro-2H-oxazolo[3,2-a]pyridine-5-carbonitrile
COBI-017398489-26-4tert-butyl 3-oxoazetidine-1-carboxylate
COBI-0181597407-55-0tert-butyl 3-((3S,5R,8aS)-5-cyano-3-phenylhexahydro-2H-oxazolo[3,2-a]pyridin-5-yl)-3-hydroxyazetidine-1-carboxylate
COBI-0191597407-56-1tert-butyl 3-hydroxy-3-((S)-1-((S)-2-hydroxy-1-phenylethyl)piperidin-2-yl)azetidine-1-carboxylate
COBI-0201597407-57-2 (Freebase)3-((S)-1-((S)-2-hydroxy-1-phenylethyl)piperidin-2-yl)azetidin-3-ol
COBI-0211597407-58-3(3-hydroxy-3-((S)-1-((S)-2-hydroxy-1-phenylethyl)piperidin-2-yl)azetidin-1-yl)(2,3,4-trifluorophenyl)methanone
COBI-0221597407-59-4 (Freebase)(S)-(3-hydroxy-3-(piperidin-2-yl)azetidin-1-yl)(2,3,4-trifluorophenyl)methanone hydrochloride
ProcessRoute 3Steps 8 · Total yield 102.6 g
Synthetic routes & intermediates Route 3
CodeCAS No.Intermediate
COBI-011934663-52-2(S)-tert-butyl 2-(1-(3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzoyl)-3-hydroxyazetidin-3-yl)piperidine-1-carboxylate
COBI-017398489-26-4tert-butyl 3-oxoazetidine-1-carboxylate
COBI-023109-04-62-bromopyridine
COBI-0241415560-24-5tert-butyl 3-hydroxy-3-(pyridin-2-yl)azetidine-1-carboxylate
COBI-0251415564-55-4-
COBI-0261415560-00-72,2,2-trifluoro-1-(3-hydroxy-3-(pyridin-2-yl)azetidin-1-yl)ethanone hydrochloride
COBI-0271799970-85-62,2,2-trifluoro-1-(3-hydroxy-3-(piperidin-2-yl)azetidin-1-yl)ethanone hydrochloride
COBI-0281415559-54-4tert-butyl 2-(3-hydroxy-1-(2,2,2-trifluoroacetyl)azetidin-3-yl)piperidine-1-carboxylate
COBI-029934666-06-5tert-butyl 2-(3-hydroxyazetidin-3-yl)piperidine-1-carboxylate
COBI-030833451-96-03,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzoyl chloride

Frequently asked questions

What are the approved indications of Cobimetinib Fumarate?

Approved indications include: 黑色素瘤.

When does the Cobimetinib Fumarate patent expire?

Based on public sources, the Cobimetinib Fumarate patent expires in 2029.

How many synthesis routes are recorded for Cobimetinib Fumarate?

3 synthesis routes are recorded; the shortest is 6 steps with 20.66 g total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Cobimetinib Fumarate intermediates?

1 intermediate CAS of Cobimetinib Fumarate are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Cobimetinib Fumarate intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-24